A detailed history of Cardiff Park Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Cardiff Park Advisors, LLC holds 14,885 shares of HLN stock, worth $139,770. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,885
Previous 14,885 -0.0%
Holding current value
$139,770
Previous $122,000 28.69%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$8.02 - $8.67 $609 - $658
-76 Reduced 0.51%
14,885 $126,000
Q3 2023

Nov 13, 2023

BUY
$7.85 - $8.94 $117,443 - $133,751
14,961 New
14,961 $124,000
Q3 2022

Nov 08, 2022

BUY
$5.63 - $7.5 $77,468 - $103,200
13,760 New
13,760 $84,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Cardiff Park Advisors, LLC Portfolio

Follow Cardiff Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardiff Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cardiff Park Advisors, LLC with notifications on news.